Juniper Investment Company’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.5M Hold
6,939,357
17.35% 3
2026
Q1
$63.4M Hold
6,939,357
20.22% 2
2025
Q4
$51.6M Hold
6,939,357
17.75% 4
2025
Q3
$46.4M Hold
6,939,357
17.76% 3
2025
Q2
$45.9M Hold
6,939,357
18.89% 3
2025
Q1
$63.5M Hold
6,939,357
28.55% 1
2024
Q4
$72.9M Hold
6,939,357
28.71% 1
2024
Q3
$82.9M Buy
6,939,357
+105,500
+2% +$912K 34.62% 1
2024
Q2
$39.3M Hold
6,833,857
18.84% 3
2024
Q1
$35.5M Hold
6,833,857
17.68% 2
2023
Q4
$36M Hold
6,833,857
19.15% 3
2023
Q3
$22.6M Buy
6,833,857
+176,870
+3% +$621K 14.32% 3
2023
Q2
$19.2M Buy
6,656,987
+2,063,524
+45% +$3.96M 12.22% 4
2023
Q1
$4.92M Hold
4,593,463
3.59% 9
2022
Q4
$12M Buy
4,593,463
+1,215,414
+36% +$5.31M 8.8% 5
2022
Q3
$23.6M Buy
3,378,049
+616,392
+22% +$4.83M 19.96% 2
2022
Q2
$18.8M Hold
2,761,657
16.34% 2
2022
Q1
$38.9M Buy
2,761,657
+13,450
+0.5% +$180K 24.42% 2
2021
Q4
$39.8M Buy
2,748,207
+2,144,846
+355% +$30.5M 26.89% 1
2021
Q3
$8.54M Buy
+603,361
New +$9.28M 7.51% 6

Other funds holding BVS

Juniper Investment Company's BVS Position: Q2 2026 in Review

Juniper Investment Company held its Bioventus (BVS) position steady in Q2 2026 at 6,939,357 shares worth $65.5M. The position accounts for 17.35% of the portfolio, ranked #3.

Juniper Investment Company first reported a position in BVS in Q3 2021 and has held it in 20 quarters since. The position peaked at $82.9M in Q3 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Juniper Investment Company held 6,939,357 shares of Bioventus worth $65.5M as of Q2 2026.
  • Juniper Investment Company left its Bioventus share count unchanged in Q2 2026.
  • Bioventus made up 17.35% of Juniper Investment Company's portfolio in Q2 2026, its #3 holding.
  • Juniper Investment Company first reported a position in Bioventus in Q3 2021 and has held it in 20 quarters since.
  • Juniper Investment Company's Bioventus position peaked at $82.9M in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Juniper Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.